Redwood Pharma AB (OSTO:REDW) Total Liabilities : kr1.49 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Redwood Pharma AB Total Liabilities?

Redwood Pharma AB's Total Liabilities for the quarter that ended in Mar. 2024 was kr1.49 Mil.

Redwood Pharma AB's quarterly Total Liabilities declined from Jun. 2023 (kr1.92 Mil) to Sep. 2023 (kr1.01 Mil) but then increased from Sep. 2023 (kr1.01 Mil) to Mar. 2024 (kr1.49 Mil).

Redwood Pharma AB's annual Total Liabilities declined from Dec. 2020 (kr5.77 Mil) to Dec. 2021 (kr5.32 Mil) and declined from Dec. 2021 (kr5.32 Mil) to Dec. 2022 (kr2.91 Mil).

Redwood Pharma AB Total Liabilities Historical Data

The historical data trend for Redwood Pharma AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redwood Pharma AB Total Liabilities Chart

Redwood Pharma AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

4.10

2.27

5.77

5.32

2.91

Redwood Pharma AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Total Liabilities	Get a 7-Day Free Trial															2.91	1.61	1.92	1.01	1.49

Redwood Pharma AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Redwood Pharma AB's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.912	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.91

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	18.217	-	15.304
	=	2.91

Redwood Pharma AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.487	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1.49

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	11.676	-	10.189
	=	1.49

Redwood Pharma AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Redwood Pharma AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Redwood Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Redwood Pharma AB (OSTO:REDW) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

9JV0:Germany

Address

Ringvagen 100E, 9th Floor, Stockholm, SWE, 118 60

Website

http://www.redwoodpharma.se

Redwood Pharma AB is engaged in developing new ophthalmic pharmaceutical therapies for unmet market needs. Its development product is a new therapy to treat chronic Dry Eye Disease (DED) in post-menopausal women.

Redwood Pharma AB Headlines

No Headlines